共 152 条
- [1] Dabelea D(2014)Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009 JAMA 311 1778-1786
- [2] Mayer-Davis EJ(1996)Increased incidence of non-insulin-dependent diabetes mellitus among adolescents J Pediatr 128 608-615
- [3] Saydah S(2017)Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012 N Engl J Med 376 1419-1429
- [4] Imperatore G(2012)Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislation Paediatr Drugs 14 283-294
- [5] Linder B(2019)Impact of Regulatory incentive programs on the future of pediatric drug development Ther Innov Regul Sci 53 609-614
- [6] Divers J(2002)Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial Diabetes Care 25 89-94
- [7] Pinhas-Hamiel O(2007)Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study Diabetes Care 30 790-794
- [8] Dolan LM(2018)Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes Diabetes Care 41 1717-1725
- [9] Daniels SR(2018)A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2) Eur J Pediatr 177 1497-1503
- [10] Standiford D(2019)Liraglutide in children and adolescents with type 2 diabetes N Engl J Med 381 637-646